Zerbaxa

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?
Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?
Fierce Pharma
Merck
Cubist Pharma
Zerbaxa
FDA
hospital-acquired infections
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Full Results of Merck’s Zerbaxa Trial Show Drug Is on Par With Meropenem as Pneumonia Treatment
Full Results of Merck’s Zerbaxa Trial Show Drug Is on Par With Meropenem as Pneumonia Treatment
BioSpace
Merck
Zerbaxa
nosocomial pneumonia
hospital-acquired pneumonia
meropenem
Flag link:
Merck to file for new use for antibiotic Zerbaxa
Merck to file for new use for antibiotic Zerbaxa
Pharmaforum
Merck
Zerbaxa
hospital-acquired bacterial pneumonia
Flag link:
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Yahoo
Merck
Zostavax
vaccines
infectious diseases
Zerbaxa
Flag link:
New Antibiotic Against Drug-Resistant Bacteria Now Available
New Antibiotic Against Drug-Resistant Bacteria Now Available
Yahoo
antibiotics
antibiotic resistance
Zerbaxa
Canada
Flag link:
Merck antibiotic combo Zerbaxa shows efficacy in complicated infections
Merck antibiotic combo Zerbaxa shows efficacy in complicated infections
BioPharma Dive
Merck
Zerbaxa
complicated urinary tract infections
Flag link:
Cubist: Zerbaxa Upholds The Potential To Replace Cubicin
Cubist: Zerbaxa Upholds The Potential To Replace Cubicin
Seeking Alpha
Cubist Pharma
antibiotics
Zerbaxa
Cubicin
Merck
Flag link:
4 Potential Blockbuster Drugs The FDA Just Approved
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
Flag link:
Merck Finally Gets Some Good News on Cubist
Merck Finally Gets Some Good News on Cubist
WSJ Online
Merck
Cubist
FDA
M&A
Zerbaxa
Flag link:
FDA approves Cubists' drug for antibiotic-resistant bacteria
FDA approves Cubists' drug for antibiotic-resistant bacteria
Yahoo/Reuters
Cubist Pharmaceuticals
Zerbaxa
antibiotics
Flag link:
Cubist, Enanta and Vertex still await FDA approval decisions this year
Cubist, Enanta and Vertex still await FDA approval decisions this year
Bizjournals.com
Cubist
Enanta
Vertex Pharmaceuticals
FDA
Zerbaxa
ABT-450
Kalydeco
Flag link:
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Motley Fool
Cubist Pharmaceuticals
Sivextro
Cubicin
anti-infectives
Zerbaxa
Flag link: